top of page
biotechnology sector

Fostering the Finnish Biotech Industry since 1997

Finnish Bioindustries FIB is Finland's biotechnology industry association. It is a private and independent non-profit organisation.

Member companies represent all life science areas, from healthcare and functional foods to biomaterials.

​Biotechnology is one of the fastest growing industries in the world offering revolutionary solutions to some of the most pressing challenges of our time.

Biotechnology is one of the fastest growing industries in the world offering revolutionary solutions to some of the most pressing challenges of our time.

1.55

USD Trillion

The global biotechnology market was valued at USD 1.55 trillion in 2023.

13.96

%

CAGR 2024 - 2030

The projected compound annual growth rate (CAGR) is 13.96% from 2024 to 2030.

Finnish Bioindustries participates in national and international technology programs to commercialise and promote new areas of biotechnology.

Being a technology-intensive industry, many of the biotechnology issues concern international research and technological development. Finnish Bioindustries is a national member of EuropaBio (European Association for Biotechnology), which was founded in 1996 to promote the European biotechnology industry. FIB is also a member of the US-based BIO (Biotechnology Industry Organisation) and the Australian AusBiotech.

Finnish Bioindustries participates - EuropaBio
Finnish Bioindustries participates - Bio Biotechnology
​The biotechnology sector is one of the most innovative industries in the European Union EU, with almost 7,300 patent applications. Finnish companies have a vital role in this developments.

The biotechnology sector is one of the most innovative industries in the European Union EU, with almost 7,300 patent applications.
Finnish companies have a vital role in this developments.

823.5

USD Billion

The global biotechnology market was valued at USD 823.5 billion in 2021.

9.4

%

CAGR 2022 - 2030

The projected compound annual growth rate (CAGR) is 9.4% from 2022 to 2030.

For updates and News

For more information

Alexandra Peth, Managing Director Finnish Bioindustries FIB
Alexandra Peth

Managing Director
Finnish Bioindustries FIB

Eteläranta 10, FI-00131 Helsinki

Board of Directors

With a commitment to excellence, innovation, and corporate governance, our Board of Directors plays a pivotal role in steering FIB towards sustainable growth and success.

Maarit Merla
Maarit Merla

Kansallinen Lääkekehityskeskus Oy

Chair
Mari Björkman
Mari Björkman

Helsinki Innovation Services (HIS)

Marco Hautalahti
Marco Hautalahti

Finnish Biobank Cooperative FINBB

Kaisa Helminen
Kaisa Helminen

Aiforia Technologies Oy

Tarja Hirvensalo
Tarja Hirvensalo

Medix Biochemica Oy

Lotte Bruns
Lotte Bruns

Orion Oyj

Antti Nieminen
Antti Nieminen

Biovian Oy

Lasse Leino
Lasse Leino

DelSiTech Oy

Sara Kangaspeska
Sara Kangaspeska

Innovestor Life Science Oy

Pekka Kekki
Pekka Kekki

Roal Oy

bottom of page